Literature DB >> 3754548

Studies on macrocyclic lactone antibiotics. VIII. Absolute structures of rhizoxin and a related compound.

S Iwasaki, M Namikoshi, H Kobayashi, J Furukawa, S Okuda, A Itai, A Kasuya, Y Iitaka, Z Sato.   

Abstract

The absolute structure of rhizoxin, a potent antifungal and antitumor antibiotic, was determined by interrelation with compound 2 whose structure was established by X-ray analysis. Since a 18OH group was introduced at C-3 on a hydrolytic cleavage of C-2, C-3 epoxy group with alkaline H2(18)O, the original epoxy oxygen should be retained at C-2. The stereo-chemistry at C-2 and C-3 positions in rhizoxin was, therefore, determined as 2R,3S.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3754548     DOI: 10.7164/antibiotics.39.424

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  6 in total

1.  Polyketide proofreading by an acyltransferase-like enzyme.

Authors:  Katja Jensen; Holger Niederkrüger; Katrin Zimmermann; Anna L Vagstad; Jana Moldenhauer; Nicole Brendel; Sarah Frank; Petra Pöplau; Christoph Kohlhaas; Craig A Townsend; Marco Oldiges; Christian Hertweck; Jörn Piel
Journal:  Chem Biol       Date:  2012-03-23

2.  Bacterial endosymbiosis is widely present among zygomycetes but does not contribute to the pathogenesis of mucormycosis.

Authors:  Ashraf S Ibrahim; Teclegiorgis Gebremariam; Mingfu Liu; Georgios Chamilos; Dimitrios Kontoyiannis; Richard Mink; Kyung J Kwon-Chung; Yue Fu; Christopher D Skory; John E Edwards; Brad Spellberg
Journal:  J Infect Dis       Date:  2008-10-01       Impact factor: 5.226

3.  Intracellular activation and cytotoxic action of RS-1541 against cultured human tumor cells.

Authors:  T Takatori; T Koizumi; T Tokui; Y Mitsuhashi; A Shiraishi; T Tsuruo
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

4.  Rhizoxin resistant mutants with an altered beta-tubulin gene in Aspergillus nidulans.

Authors:  M Takahashi; H Kobayashi; S Iwasaki
Journal:  Mol Gen Genet       Date:  1989-12

5.  Phase II clinical trials with rhizoxin in breast cancer and melanoma. The EORTC Early Clinical Trials Group.

Authors:  A R Hanauske; G Catimel; S Aamdal; W ten Bokkel Huinink; R Paridaens; N Pavlidis; S B Kaye; A te Velde; J Wanders; J Verweij
Journal:  Br J Cancer       Date:  1996-02       Impact factor: 7.640

6.  Ring-Closing Metathesis Approaches towards the Total Synthesis of Rhizoxins.

Authors:  Marc Liniger; Christian M Neuhaus; Karl-Heinz Altmann
Journal:  Molecules       Date:  2020-10-02       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.